Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck

Acta Oto-Laryngologica

Volumn 116, Issue 2, 1996, Pages 345-349

  Kau, Reinhardt ^a   Arnold, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Octreotide; Somatostatin receptor scintigraphy; Tumor of the APUD system

Indexed keywords

OCTREOTIDE; PENTETREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLOMUS TUMOR; HEAD AND NECK CANCER; HUMAN; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; SCINTIGRAPHY;

EID: 0029979188     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489609137855     Document Type: Article

References (19)

1. Krulich L, Dhariwal AP, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 1968; 83: 783-90.
2. Brazeau P, Vale W, Burgus R et al. Hypothalamic polypetide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77-9.
3. Reichlin S. Somatostatin (part I). N Engl J Med 1983; 309: 1495-501.
4. Reichlin S. Somatostatin (part II). N Engl J Med 1983; 309:1556-63.
5. Lewin MJM. Somatostatin receptors. Scand J Gastroenterol 1986; Suppl 119: 42-7.
6. Lucey MR. Endogenous somatostatin and the gut. Gut 1986; 27: 451-7.
7. Iversen LL. Non opioid neuropeptides in mammalian CNS. Ann Rev Pharmacol Toxicol 1983; 23: 1-5.
8. Reubi JC, Landolt AM. High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 1984; 59: 1148-51.
9. Reubi JC, Lang W, Maurer R et al. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987; 47: 5758-64.
10. Reubi JC, Maurer R, von Werder K et al. Somatostatin receptors in human endocrine tumors. Cancer Res 1987; 47: 551-8.
11. Sagman U, Mullen JB, Kovacs K et al. Identification of somatostatin receptors in human small cell lung carcinoma. Cancer 1990; 66: 2129-33.
12. Reubi JC, Kvols L, Krenning E et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 39: 78-81.
13. Reubi JC, Chayvialle JA, Franc B et al. Somatostatin receptors and somato statin content in medullary thyroid carcinomas. Lab Invest 1991; 64: 567-73.
14. Mascardo RN, Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology 1982; 111: 1394-7.
15. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991; 12: 450-82.
16. Arnold R. Therapeutic strategies in the management of endocrine GEP tumors. Eur J Clin Invest 1990; 20: 82-90.
17. Arnold R, Neuhaus C, Trautmann ME. Therapie endokriner gastroentero-pankreatischer Tumoren mit dem Somatostatin-Analogon Octreotid. Dtsch med Wschr 1992; 117: 1067-71.
18. Arnold R. Diagnosis and therapy of active endocrine pancreatic tumors Schweiz. Rundschau-Med-Prax. 1994; 828-32.
19. Hurst RD, Moddlin IM, Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors. Digestion 1993; Suppl 1: 88-91.